Vasopressin Transdermal Patch 0.4 mg/24hr from Japan
Controlled-release transdermal patch delivering 0.4 mg vasopressin over 24 hours for chronic diabetes insipidus management. Note specifies transdermal systems; classified 3004.39.0045 as measured-dose hormone product of heading 2937.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Adhesive matrix composition and permeation testing reports required for device-drug combo clearance
• Shelf-life extension data critical for transdermal stability during ocean freight